ArticleERJ open research2022

CFTR modulator use and risk of nontuberculous mycobacteria positivity in cystic fibrosis, 2011-2018.

Emily E Ricotta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.